Five Years Follow-up of Imlifidase Desensitized Kidney Transplant Recipients. [PDF]
Lorant T +11 more
europepmc +1 more source
Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report. [PDF]
Reuter S +40 more
europepmc +1 more source
E I, Gudkova, P P, Sakharov
openaire +1 more source
Peanut Oral Immunotherapy in Children: An Italian Single-Center Retrospective Cohort Study. [PDF]
Pessina B +11 more
europepmc +1 more source
Sensitization and Deceased-Donor Kidney Transplant Access in France. [PDF]
Bertrand D +12 more
europepmc +1 more source
A retrospective cohort study of infective complications and graft outcomes over 5 years in ABO-incompatible kidney transplant recipients: experience from a tertiary care centre in Saudi Arabia. [PDF]
Mohsin B +8 more
europepmc +1 more source
Accessing the Impacts of the Calculated Panel Reactive Antibody Value on a Lung Transplant Waitlist: A Latin American Experience. [PDF]
Dos Santos SL +9 more
europepmc +1 more source
Long Term Outcomes of Lung Transplantation in Sensitized Patients Following Eculizumab Use With the Desensitization Protocol. [PDF]
Miyashita Y +12 more
europepmc +1 more source

